Picture of Ergomed logo

ERGO Ergomed News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

REG - Ergomed plc - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200214:nRSN0317Da

RNS Number : 0317D  Ergomed plc  14 February 2020

 PRESS RELEASE

 

 

Ergomed Plc

("Ergomed" or the "Company")

 

Directors' Dealings

 

 

Guildford, UK - 14 February 2020 - Ergomed plc (LSE: ERGO) ("Ergomed" or the
"Company"), a company focused on providing specialised services to the
pharmaceutical industry, announces the purchase of ordinary  shares of 1
pence each ("Shares") by four Directors of the Company.

 

 PDMR                  Position                 Shares acquired  Purchase price (£)   Date of purchase  Resultant shareholding in the Company (Shares)
 Rolf Soderstrom((1))  Non-Executive Director   10,000           4.56                 11 February 2020  10,000
 Dr Jim Esinhart       Non-Executive Director   10,000           4.56                 11 February 2020  10,000
 Ian Johnson           Non-Executive Director   10,000           4.56                 11 February 2020  10,000
 Lewis Cameron         Chief Operating Officer  10,910           4.56                 12 February 2020  10,910

 

(1)   Note: includes Shares acquired by Linda Davey, being a person closely
associated with Rolf Soderstrom.

 

The notification below, made in accordance with the requirements of the EU
Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated ("PCA") with them.

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Rolf Soderstrom
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Ergomed Plc
 b)  Legal Entity Identifier                                      213800BVS8I9VMC1AP84
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                   GB00BN7ZCY67
 b)  Nature of the transaction                                    Purchase of Shares
 c)  Currency                                                     GBP
 d)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
     £4.56                                                                                                  5,000

 e)  Aggregated information                                       Volume: 5,000 ordinary shares of 1 pence each, purchase price of 456 pence per

                                                            share
     - Aggregated volume

                                                            Aggregated: £22,800.00
     - Price

     - Aggregated total
 f)  Date of the transaction                                      11 February 2020
 g)  Place of the transaction                                     London Stock Exchange, AIM

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Linda Davey
 2   Reason for the notification
 a)  Position/status                                              PCA with Rolf Soderstrom, Non-Executive Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Ergomed Plc
 b)  Legal Entity Identifier                                      213800BVS8I9VMC1AP84
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                   GB00BN7ZCY67
 b)  Nature of the transaction                                    Purchase of Shares
 c)  Currency                                                     GBP
 d)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
     £4.56                                                                                                  5,000

 e)  Aggregated information                                       Volume: 5,000 ordinary shares of 1 pence each, purchase price of 456 pence per

                                                            share
     - Aggregated volume

                                                            Aggregated: £22,800.00
     - Price

     - Aggregated total
 f)  Date of the transaction                                      11 February 2020
 g)  Place of the transaction                                     London Stock Exchange, AIM

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Jim Esinhart, PhD
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Ergomed Plc
 b)  Legal Entity Identifier                                      213800BVS8I9VMC1AP84
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                   GB00BN7ZCY67
 b)  Nature of the transaction                                    Purchase of Shares
 c)  Currency                                                     GBP
 d)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     £4.56                                                                                                10,000

 e)  Aggregated information                                       Volume: 10,000 ordinary shares of 1 pence each, purchase price of 456 pence

                                                            per share
     - Aggregated volume

                                                            Aggregated: £45,600.00
     - Price

     - Aggregated total
 f)  Date of the transaction                                      11 February 2020
 g)  Place of the transaction                                     London Stock Exchange, AIM

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Ian Johnson
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Ergomed Plc
 b)  Legal Entity Identifier                                      213800BVS8I9VMC1AP84
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BN7ZCY67
 b)  Nature of the transaction                                    Purchase of Shares
 c)  Currency                                                     GBP
 d)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     £4.56                                                                                                10,000

 e)  Aggregated information                                       Volume: 10,000 ordinary shares of 1 pence each, purchase price of 456 pence

                                                            per share
     - Aggregated volume

                                                            Aggregated: £45,600.00
     - Price

     - Aggregated total

 f)  Date of the transaction                                      11 February 2020
 g)  Place of the transaction                                     London Stock Exchange, AIM

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Lewis Cameron
 2   Reason for the notification
 a)  Position/status                                              Chief Operating Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Ergomed Plc
 b)  Legal Entity Identifier                                      213800BVS8I9VMC1AP84
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BN7ZCY67
 b)  Nature of the transaction                                    Purchase of Shares
 c)  Currency                                                     GBP
 d)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     £4.56                                                                                                10,910

 e)  Aggregated information                                       Volume: 10,910 ordinary shares of 1 pence each, purchase price of 456 pence

                                                            per share
     - Aggregated volume

                                                            Aggregated: £49,749.60
     - Price

     - Aggregated total
 f)  Date of the transaction                                      12 February 2020
 g)  Place of the transaction                                     London Stock Exchange, AIM

 

 

ENDS

 

Enquiries:

 

 Ergomed plc                                             Tel: +44 (0) 1483 402 975
 Miroslav Reljanović (Executive Chairman)
 Richard Barfield (Chief Financial Officer)

 Numis Securities Limited                               Tel: +44 (0) 20 7260 1000
 Freddie Barnfield / Huw Jeremy (Nominated Adviser)
 James Black (Broker)

 Consilium Strategic Communications - for UK enquiries  Tel: +44 (0) 20 3709 5700
 Chris Gardner / Sue Stuart                             ergomed@consilium-comms.com
 Matthew Neal / Olivia Manser

 

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning
all phases of clinical trials, post-approval pharmacovigilance and medical
information. Ergomed's fast-growing, profitable services business includes a
full range of high-quality contract research and clinical trial management
(CRO) services under the Ergomed brand together with an industry-leading suite
of specialist pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand, and an internationally recognized specialist expertise
in orphan drug development, under the PSR brand. For further information,
visit: http://ergomedplc.com (http://ergomedplc.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.   END  DSHKZGMZVDZGGZG

Recent news on Ergomed

See all news